A YEAR IN REVIEW 2025
Message from the Board Chair It has been another exceptional year for Northern Sydney Local Health District (NSLHD). In 2025, we’ve seen remarkable progress across our services, with many achievements that reflect the dedication, skill and innovation of our staff.
As we move forward with new initiatives, our incredible staff continue to deliver world-class healthcare with compassion and professionalism. Whether at the bedside, behind the scenes, or in leadership roles, their focus on delivering the highest standard of care is central to everything we achieve. It’s been a full and fulfilling year, as we partner with the community to build a healthier future. We continue to work towards net zero emissions by 2035 in the areas we can control. From cutting waste to improving energy efficiency, our teams are making practical changes that protect the environment while continuing to deliver high-quality care. Plans are moving ahead for the Sydney North HealthCARE Innovation Precinct at the St Leonards campus, with Royal North Shore Hospital at its centre. This visionary project brings together healthcare, research, education, and industry partners to work more closely together in order to improve health outcomes and make care more personalised and effective. We’re currently developing a strategic plan for the precinct focused on three key areas: delivering high-value healthcare, using clinical trials as part of treatment, and embedding education into everyday practice. This year also saw major progress on the $526.8 million Ryde Hospital redevelopment, with early works completed, interim
facilities delivered, and the foundations for the construction on the main site started. The new hospital will include an MRI machine, further enhancing diagnostic services for the community. The transition of Northern Beaches Hospital from current operator Healthscope to the NSW Health public system represents one of the most significant milestones in our district. The hospital’s leadership team and staff have demonstrated remarkable commitment and resilience, working collaboratively with NSW Health and NSLHD. As we move toward integration in 2026, we look forward to building on this strong foundation to deliver a truly unified, high-performing health service for the people of the Northern Beaches. I would like to thank district staff and everyone involved in the planning to ensure a smooth transition. Finally, I want to send a thank you to all our caring staff and volunteers for their extraordinary commitment. It is notable how engaged NSLHD staff are in getting the best outcomes for patients, their families and the community. I also want to thank all the donors whose generosity helps brings to life so much important work across the health system. I look forward to 2026 and seeing our many exciting and innovative projects, plans and clinical work continue. Trevor Danos AM Board Chair Northern Sydney Local Health District
NSLHD 2025 Year in Review
2
Message from the Chief Executive It’s been an incredible 2025 for the district, and I’m so proud of everything our people have achieved. Their expertise, commitment and care continue to inspire, and it is always a privilege to look back and reflect on the impact they have made.
This was a year of exceptional health delivery to our community and the numbers speak volumes. Our staff performed over 35,000 surgical procedures, cared for over 229, 000 people in emergency departments and cared for more than 4,580 babies born in our hospitals. Behind these figures, however, lies a world of experience, hard work and innovation. Our clinicians are translating cutting-edge research into real-world care. This year saw the launch of a new service offering life-changing stem cell treatment for people living with multiple sclerosis. Across the district, 252 clinical trials are currently underway, with clinicians embedding trials as therapy. The trials include investigations into improving bowel cancer screening methods, testing a game-changing device to monitor babies during labour, and developing an app that offers rehabilitation for patients with lung disease. Staff are also researching how AI can be used in treatment, including in pancreatic cancer data analysis, radiation oncology and muscle imaging. Our new research centre, NORTH STAR VNP, has already recruited trial participants and our patients are part of 18 international trials. Thanks to fast-tracked access to studies from the world-renowned Memorial Sloan Kettering Cancer Centre in New York, NSLHD patients—and those in rural and remote communities— now have unprecedented opportunities to participate in new cancer research. NSLHD also strengthened its commitment to quality by embedding patient feedback into service design, ensuring care is not only clinically excellent but also deeply responsive to individual needs.
We’ve made strong progress in rolling-out the Single Digital Patient Record (SDPR), a once-in-a-generation health program that will revolutionise care. With the record, clinicians will be able to access a patient’s medical information in real time from a single source. This year, we launched the next phase of the program with a focus on the district’s go- live readiness. We have had over 50 NSLHD staff involved in the project, all of them playing an important role in shaping one of the largest quality improvement initiatives in NSW Health’s history. The NSW Government has announced its intention to assume management and operation of Northern Beaches Hospital. An in-principle agreement has been reached for the hospital to transition from its current operator, Healthscope, to Northern Sydney Local Health District (NSLHD). Significant planning is already underway to ensure a smooth and well-coordinated transition of services and staff to the public health system. I would like to thank the many staff who have contributed to this important work so far. We look forward to welcoming the Northern Beaches Hospital team to NSW Health in the coming months. I also want to acknowledge the strong fiscal management across the district, particularly in the face of ongoing financial pressures. My sincere thanks to our Finance team for their hard work, effort and expertise applied to managing our resources over the past year. Thank you to all staff, patients, volunteers and the community for supporting the district throughout 2025. I’m excited for what we’ll achieve together in 2026. Adjunct Professor Anthony M. Schembri AM Chief Executive Northern Sydney Local Health District
NSLHD 2025 Year in Review
3
NSLHD recognised for leadership in LGBTIQ+ inclusive care
NSLHD LGBTIQ+ Strategy Project Manager Jemma Clifton and Chief Executive Anthony Schembri are presented with the award by ACON representatives Francisco Lopez and Tidge Backhouse (right)
The district was recognised with a prestigious Gold Service Provider Award for its commitment to inclusive healthcare, following its submission to the Health + Wellbeing Equality Index that is led by Australia’s largest LGBTQ health
organisation, ACON. To celebrate the achievement, the district held a vibrant awards ceremony where ACON representatives Francisco Lopez and Tidge Backhouse presented the trophy to Chief Executive Anthony Schembri and NSLHD The index measures the shifting practice within health, wellbeing, and human services. Participation provides service providers with clear guidelines for getting started, as well as a reportable gap analysis of their current practice. This analysis can LGBTIQ+ Strategy Project Manager Jemma Clifton.
then be used to progress work in LGBTQ+-inclusive service provision. Jemma said the district had made significant strides in improving care for LGBTIQ+ communities and the achievement would provide a foundation for the next part of the journey. “There is still work to be done to achieve our vision: that LGBTIQ+ people in Northern Sydney attain equal health outcomes to the general population,” she said.
“Our services are here for you. Expect to be respected, and please let us know if you are not receiving the care you need so that we can work to support you.”
If you would like to share your experiences as an LGBTIQ+ patient, please use the district’s bespoke LGBTIQ+ Patient Experience Survey here: https://lnkd. in/grHk2VMQ.
NSLHD 2025 Year in Review
4
Pioneering study to improve sleep and reduce musculoskeletal pain
An innovative study, led by a team of researchers from the Kolling Institute,
has the potential to change the way
osteoarthritis and low back pain are managed. More than $4.7 million was awarded to the project through the Medical Research Future Fund’s program for early-to mid-career researchers. Study lead Associate Professor Michelle Hall said that chronic muscle pain and poor sleep often go hand-in-hand, yet sleep is rarely addressed in standard musculoskeletal care. “Our program however, is targeting insomnia as a first line treatment for a range of musculoskeletal pain conditions, including hip and knee osteoarthritis, and low back pain,” said the University of Sydney researcher. “These conditions are the leading cause of disability worldwide and co-exist with poor sleep. We know that insomnia affects up to 80 per cent of people with chronic musculoskeletal pain, and poor sleep actually worsens chronic pain. “Our ground-breaking program is measuring the impact of adding cognitive behavioral therapy to physiotherapy care for people with muscle pain and insomnia. “This type of therapy is a proven treatment for both sleep and
Associate Professor Michelle Hall
chronic pain, yet it is not routinely offered due to limited psychologist availability and funding. “Physiotherapists are well-positioned to address this care gap, given they typically manage people with chronic musculoskeletal conditions and are more widely available than clinical psychologists. “Our approach could also represent a significant financial saving. “Earlier trials have demonstrated a reduction in medication use and costs, and given the $7 billion cost of medications for osteoarthritis and low back pain each year, the projected savings could exceed $60 million a year.”
The program will be adopted across nine public hospitals in NSW, Queensland and Western Australia, and will involve seven Australian universities and a UK institution. “We would like to thank the many consumers and partners who have helped us develop this project. It has the potential to be upscaled and could improve models of care and patient outcomes for a large number of people across Australia and internationally,” Michelle said. “We are looking forward to progressing this important research and reducing the severity of pain experienced by the community.
NSLHD 2025 Year in Review
5
Researchers identify new gene linked to Meniere’s disease In a crucial step towards better understanding
Meniere’s disease, researchers at the Kolling Institute discovered a gene mutation which could greatly inform future treatment of the disease.
Yolanda Liu from the Kolling Institute’s Meniere’s Disease and Neuroscience Laboratory
Meniere’s disease is a rare inner ear disease associated with sensorineural hearing loss, vertigo and debilitating tinnitus. There is currently no cure with treatment largely aimed at managing symptoms. Meniere’s can be an inherited condition, with approximately 10 per cent of patients having one or more relatives affected by it. However, the latest research, led by world leading investigator Professor Jose Antonio Lopez-Escamez, indicates the inherited or genetic form of the disease may be more common than first realised. The team discovered a rare mutation of the GJD3 gene in both patients with and without a genetic history of the disease. It is the first time this gene has been linked to any disease.
More than 400 people with Meniere’s disease were involved in the study, with 18 people or 4.4 per cent of the group found to have the genetic mutation, a statistically significant percentage. Professor Lopez-Escamez said this new understanding could lead to a greater number of patients undergoing genetic testing. “Many people will say that they don’t have the genetic form of the disease, but this research indicates there are many more people whose disease is directly linked to their genetic make-up,” he said. “This is important as it will inform how we treat the disease going forward, particularly given the different forms of the disease and the exciting advances with gene therapy.
“Groundbreaking gene therapy is already being adopted internationally to treat hearing loss, and we anticipate this approach will be developed further to treat Meniere’s disease in the years to come.” The latest research by Professor Lopez-Escamez and his team also identified a connexin (or connecting protein) in the tectorial membrane of the organ of Corti – or the hearing organ. “This is the first time that a connexin has been found in this part of the ear, and it may support the view that connexins regulate the microenvironment in the ear and influence hearing,” he said. “We believe the mutated gene is impairing the function of the connexins within the ear and impacting hearing ability.”
NSLHD 2025 Year in Review
6
RNSH unveils new surgical robot in honour of philanthropist
A quiet act of generosity by philanthropist Alexandria Phirros has brought a major advancement in surgical care to Royal North Shore Hospital, with the arrival of a next-generation robotic surgical system now named in her honour. The new Da Vinci Xi surgical robot, known as Alexis, is set to change the future for patients across NSLHD by expanding access to safer, less invasive procedures and supporting the training of Australia’s next generation of surgical leaders. Made possible by a significant bequest from Alexandria’s estate, the project was delivered through the NORTH Foundation. To mark the arrival of Alexis, RNSH hosted a special event with Alexandria’s loved ones in attendance, acknowledging her extraordinary legacy and the lasting impact of her gift. NSLHD Chief Executive Anthony Schembri said the new technology would benefit both patients and clinical teams for years to come. “The Alexis surgical robot will enable greater surgical precision and improved outcomes for our patients,” he said. “It will enhance our ability to attract the very best surgical talent, who can now come to RNSH to train with
Celebrating go-live day with the theatre leadership team and Philips project and support staff
world-class technology.” Robotic-assisted surgery has become a trusted and advanced option in Australia over the past two decades, particularly in private hospitals. With the arrival of Alexis, RNSH now offers its own publicly available robotic platform, ensuring more patients in the public system can benefit from the same level of care. Surgeons across urology, colorectal, cardiothoracic, upper gastrointestinal, gynaecology and ENT are already trained in robotic-assisted techniques, with the first procedure using Alexis taking place in August 2025. Liver and pancreatic surgeon and Academic Lead for Robotic Surgery at RNSH, Kai Brown, said Alexandria’s gift had opened a new chapter for surgical care in the district.
“Alexandria has left a permanent legacy. She has opened a world of opportunity for not only patients, but also for our surgical team, allowing NSLHD to become a leader in minimally invasive robotic surgery,” he said. Kai said the Alexis robot allows for advanced procedures that are more precise and less invasive. “The robot has similar benefits to laparoscopic or keyhole surgery, but offers further advantages. Instead of being limited to their
hands, the surgeon controls four articulated robotic arms via a console. With 10-times
high-definition 3D magnification, it allows for extraordinary precision, dexterity and visualisation. It means many operations that once required large incisions can now be done with smaller ones, reducing pain, shortening hospital stays and speeding recovery for our patients.”
NSLHD 2025 Year in Review
7
Tiny and Mighty Café brings comfort to NICU families
Parents, staff, and Northbridge Rotary Club members stand with the new sign
The Royal North Shore Hospital’s neonatal intensive care unit launched the Tiny and Mighty Café for parents of babies who need specialised care. It’s a tiny gesture that goes a long way to comfort families with sick newborns.
In collaboration with Northbridge Rotary, the café now provides free breakfast items, drinks, and snacks to NICU families. The name of the café, Tiny and Mighty Café, was chosen through a voting system where NICU parents selected their favourite name. RNSH NICU Nurse Manager Claire Blackburn, who led the initiative, was proud of the response.
“An overwhelming number voted for the Tiny and Mighty Café,” said Claire. A NICU graduate mum also designed the café’s logo, adding a personal and meaningful touch. To ensure continued support, Northbridge Rotary vowed to deliver snacks to parents on a fortnightly basis and has secured donations from local businesses.
Peter Russell, Immediate Past President of the Northbridge Rotary Club said that the community had been eager to support the families at RNSH. “Being at the NICU can be one of the hardest times of parents’ lives. It’s good we can do a small part to help them,” he said.
NSLHD 2025 Year in Review
8
Patients receive treatment faster under new protocols at Mona Vale New protocols introduced at Mona Vale Hospital’s Urgent Care Centre have led to a reduction in wait times as nurses can start treatment immediately after triage.
Mona Vale Hospital has become the first urgent care centre (UCC) in NSW to implement Emergency Care Assessment and Treatment (ECAT) protocols. The protocols allow nurses to begin treatment immediately after triage which ultimately helps to reduce wait times and improve patient outcomes before a
medical officer, nurse practitioner or physiotherapist takes over care. The milestone followed the successful implementation of ECAT protocols across NSLHD’s emergency departments last year. Mona Vale Hospital’s UCC nurse unit manager Heidi Stojic said early adoption of the system
is helping streamline care and enhance the patient experience. “Patients are now receiving treatment faster, which helps reduce anxiety and improves their overall experience,” she said. “It’s been a really positive step for both staff and the people we care for.”
Mona Vale Hospital UCC staff on the launch day of the new ECAT protocols
NSLHD 2025 Year in Review
9
New technology removes language barrier to high-quality cancer care Two enterprising radiation therapists from the Northern Sydney Cancer Centre developed an innovative app to improve access to care for patients from diverse backgrounds.
Based at Royal North Shore Hospital, Rory Hartley and Toby Lowe produced the INSPIRE-RT app following their experience with oncology patients, including those from a non-English speaking background. Rory said clinicians know that it’s important for patients undergoing breast and liver radiation therapy to adopt the breath-hold technique to minimise the radiation dose to healthy organs such as the heart, lungs and abdominal structures. “But we were consistently seeing that patients from diverse cultural and linguistic backgrounds were not able to use the advanced technique due to language barriers, anxiety and a lack of understanding,” he said. “Concerned by the inequality in access to this important technique, we developed the mobile app to educate and coach patients to adopt the breath-hold model, and to translate the real-time coaching commands into seven commonly spoken languages.” INSPIRE-RT is a dedicated tool delivering visual and interactive instructions in an easy-to-use format. Toby said they were pleased the app was now being trialled at Royal North Shore Hospital.
“We developed INSPIRE-RT to ensure that every patient, regardless of language or background, has the opportunity to receive the highest standard of radiation therapy,” he said. “It’s about fairness, dignity, and delivering truly inclusive care, and we are so pleased that it is now supporting the delivery of care. “We hope the technology will help reduce anxiety, increase take-up of the breath-hold technique and improve workflow efficiencies.”
The innovative app gained recognition, with the Northern Sydney Cancer Centre therapists receiving an NSLHD Quality and Improvement Award. The development of the app was made possible by a generous philanthropic donation by the family of Brenda Grosz. Rory and Toby extended their thanks for the crucial funding which transformed their idea from a concept to a functional tool which may eventually assist patients internationally.
Radiation therapists Rory Hartley and Toby Lowe
10 NSLHD 2025 Year in Review
Podcast co-hosts Associate Professor Matthew Doane (left) and Professor James Elliott (right) with guest, Associate Professor Sarah Glastras (centre)
NSLHD launches Tomorrow’s Medicine Today podcast A new podcast series showcasing groundbreaking research, innovative models of care, and inspiring stories from across the district was launched this year. Tomorrow’s Medicine Today is a joint initiative presented by NSLHD and the Kolling Institute.
Chief Executive Anthony Schembri said the podcast is an important way to highlight NSLHD’s leadership in research and innovation. “Our teams are delivering truly outstanding work in healthcare and medical research,” he said. “This podcast is a great platform to share that work with our community and highlight the people behind the breakthroughs.”
Produced with the Kolling Institute, the series features clinicians, researchers and teams from across NSLHD who are shaping the future of healthcare. Podcast co-host and Kolling Institute researcher, Professor James Elliott, said the series shines a light on the depth of talent and discovery happening locally.
“Each year, Stanford University publishes a list of the top two per cent of researchers globally, and many of those names are my colleagues right here at the Kolling Institute,” he said. “That’s what inspired this podcast. It’s a chance to share the world-class research happening right here in Northern Sydney with a wider audience.”
You can listen now at https://bit.ly/nslhd-tmt or on Spotify: https://bit.ly/448P755.
11 NSLHD 2025 Year in Review
Celebrating over 100 years of innovation
The inaugural Eva Kolling Research Day provided an opportunity to honour the legacy of a true research pioneer and the significant impact of the Kolling Institute.
Established in 1920, the Kolling Institute is the oldest medical research institute in NSW. It has been at the forefront of innovation for more than a century, with its founding director, Dr W. Wilson Ingram opening Australia’s first diabetes treatment clinic. In 1931, the Kolling Institute of Medical Research was named in honour of businessman Charles Kolling, following a generous donation from his widow, Eva, who was a passionate supporter of health research. At the inaugural event, RNSH honorary archivist Catherine
Storey OAM reflected on the Kolling’s history and evolution. Academic Director Professor James Elliott said the day was an opportunity for researchers to connect with the community and highlight their work. “A key part of our research success will depend on the strength of our community ties, including community driven clinical trials and broad community involvement,” he said.
of the dedicated and skilled clinician researchers within the Kolling Institute.” Early-to-mid-career researchers presented a poster display, illustrating their commitment to improving health outcomes, driving new health policy, and realising global reach. Two awards were announced, with the Excellence in Clinical Translation Science awarded to Temitope Esther Afolabi from the Kolling’s Lab of Ageing and Pharmacology, and Excellence in Basic Science awarded to Daisy (Qinrui) Chen from the Renal Research Lab.
“I would also like to thank the NORTH Foundation for their unrelenting support, and for raising awareness
Attendees at the Eva Kolling Research Day
12 NSLHD 2025 Year in Review
Growing change at AYAH
AYAH’s music therapist Dave (second from right) with patients at the garden
At the Adolescent and Young Adult Hospice (AYAH), a small edible garden has helped to drive local sustainability efforts and foster connections among patients and their families.
It’s part of NSLHD’s broader focus on planetary health— reducing waste, growing food on site, and lowering environmental impact. Led by AYAH’s music therapist Dave Anthony, the garden is supported by partners including Kimbriki Resource Centre, Waterups Wicking Beds, Bunnings Balgowlah, and
award-winning chef, Phil, in the meals he serves our patients and families,” he said. “Each week, more than 10 kilograms of green waste is composted on-site. The fresh, seasonal produce we are growing includes eggplant, tomatoes, squash and greens.” Dave said the space was also being used for therapeutic purposes, to make each gardening session a unique experience for patients.
What began as a sustainability project is quickly becoming something even deeper. It is a way for the AYAH community to grow together, with patients and families already bringing cuttings from home and planting their own contributions to the growing space. The next chapter of the project is an Indigenous food garden, developed in partnership with Bush to Bowl and inspired by the work already underway at Mona Vale Hospital.
Ben & Jerry’s volunteers. Dave said the garden had
allowed the facility to grow its own vegetables to be used in the meals prepared at the AYAH. “Our goal is to grow seasonal,
“Myself, alongside the AYAH’s occupational and physiotherapist, use the garden to design tailored sessions for patients that improve wellbeing through physical activity and connection with nature,” Dave said.
close-to-organic produce that can be used by our
13 NSLHD 2025 Year in Review
International clinical trial to determine if diet and exercise alone can prevent knee osteoarthritis
In one of the first global clinical trials of its kind, researchers launched a study to investigate if a diet and exercise program aimed at weight loss can prevent crippling knee osteoarthritis. Researchers from the University of Sydney, NSLHD and the Kolling Institute will conduct the trial in collaboration with an international team from the United States. The Osteoarthritis Prevention Study or TOPS will compare the impact of a dietary weight-loss, exercise and weight-loss maintenance program with health education in preventing the development of knee osteoarthritis. The condition is the leading cause of disability among adults, particularly impacting women over 50 who are overweight or obese. The large-scale clinical trial will be conducted over four years, with participants receiving either a program of regular diet and exercise sessions or a healthy lifestyle program with information sessions, newsletters and text messages. Internationally recognised rheumatologist and Royal North Shore Hospital clinician Professor David Hunter said the study is one of the first prevention clinical
Professor David Hunter
trials which could help women with occasional knee pain reduce their risk of knee osteoarthritis. “Our trial has come at a time when an increasing number of people are turning to medications like Ozempic to assist with weight loss and the management of knee osteoarthritis,” he said “These weight-management medications are a feasible option for managing the condition, but questions remain around safety, cost-effectiveness and the likelihood of weight rebounding.
“Recent investigations by our team indicate that despite the promising results from trials of these medications, lifestyle interventions remain the first-line, safest and most cost-effective approach for people who are overweight, obese or living with knee osteoarthritis. “Building on that research, our clinical trial is aiming to confirm the most effective lifestyle strategies to prevent knee osteoarthritis before the condition develops.”
14 NSLHD 2025 Year in Review
NatureFix app transforms hospital green spaces into places of wellbeing across NSLHD
In an initiative to promote wellbeing and wellness for staff and visitors, NatureFix was introduced at various sites across NSLHD.
Supported by a digital app, signage, mobile audio, research data, and promotional materials, the NatureFix program aims to connect people with nature in a meaningful way. The digital platform transforms some of NSLHD’s green spaces into wellness places, unlocking the health benefits of nature through short self-guided mindfulness experiences carefully matched with natural features known to improve wellbeing. Jonathan Noyes, NSLHD’s Population Health Promotion Operations Manager, said the program helped to foster a connection to nature. “Each wellbeing zone includes a series of short wellness audio routines designed to help increase self-care and encourage meaningful moments in nature to improve mood, energy, and focus,” he said. “This initiative provides our staff with wellbeing benefits and supports them to continue to provide high-quality patient care for the community.” But NatureFix offers more than just personal wellness. It also provides an opportunity to learn about the traditional custodians of the lands on which these sites are built.
“They can understand how our mob engaged with the land and the water. “The ability to have such strong cultural knowledge shared by Elders through stories is very powerful.” The app is available across five NSLHD sites—Royal North Shore, Hornsby Ku-ring-gai, Macquarie and Mona Vale hospitals, and the Manly Adolescent and Young Adult Hospice.
Adam Cryer, Project Manager, Community Inclusion and Capacity Building, NSLHD Aboriginal and Torres Strait Islander Health Service highlighted the program’s cultural impact. “The fantastic thing about the NatureFix app is that people are actually able to stand on Country, close their eyes, and feel how these places would have felt thousands of years ago,” Adam said.
(Left to right) Adam Cryer, Project Manager, Community Inclusion and Capacity Building, NSLHD Aboriginal and Torres Strait Islander Health Service, Uncle Laurie Bimson, who speaks on the audio routines, and Population Health Promotion Operations Manager Jonathon Noyes, at the Manly Adolescent and Young Adult Hospice NatureFix Zone
For more information view the NSLHD NatureFix website: https://bit.ly/NSLHD-NatureFix.
15 NSLHD 2025 Year in Review
Dr Omar Ahmad (back right) and colleagues of the stroke unit at Hornsby Hospital
Hornsby Ku-ring-gai Hospital has joined Royal North Shore in becoming one of the small number of hospitals in Australia to boast an accredited stroke unit. The stroke unit received accreditation from the Australian Stroke Coalition and Stroke Foundation for its standard of care, training and services it offers. Hitting the right note for patients
The stroke unit treats about 210 patients a year and since 2022, began thrombolysising patients, through clot-busting medication. Dr Omar Ahmad, neurologist and head of neurology at Hornsby Ku- ring-gai Hospital, said 93 per cent of patients who presented with stroke at Hornsby were admitted into the stroke unit within the first few days of their care.
“It means people who are being managed by experienced staff, have dedicated monitoring in a dedicated stroke area, compared to patients who are on a general ward,” he said.
The accreditation will continue to be monitored every four years by the Australian Stroke Coalition, which has established a set of standards for stroke units to achieve by 2030 to improve outcomes.
“We know that patients on a general ward are more poorly managed than in a stroke unit. “This is about reducing mortality in strokes and maintaining high standards of care throughout the system.”
16 NSLHD 2025 Year in Review
Launch of Single Digital Patient Record program
NSLHD staff involved in the Single Digital Patient Record program attend the official kick-off meeting
NSLHD has officially launched the next phase of the Single Digital Patient Record (SDPR) program.
“With more than 50 staff from NSLHD contributing to the state configuration build, we’re proud to be playing a key leadership role in shaping one of the most significant quality improvement initiatives in NSW Health’s history,” Anthony said “As a co-chair of both the SDPR State Configuration Management Committee, and the Allied Health and Food and Nutrition Council,
NSLHD Chief Executive Anthony Schembri welcomed Dr Teresa Anderson AM, Chief Executive of the NSW Health SDPR Implementation Authority and her colleagues to the district, to initiate the next phase of the program, with a focus on the district’s go-live readiness. Anthony acknowledged the involvement of staff who were driving statewide digital transformation and improving care across the system.
I have had the privilege of seeing firsthand the system-wide transformation that the SDPR is delivering, not just in digital health and sustainability, but also in service delivery, quality improvement, and reducing unwarranted clinical variation. “This is much more than digital transformation. It is a major step in changing how we deliver care.” The program will undergo testing in early 2026 and be installed towards the end of go-live readiness for 2026.
Find out more on SDPR here: https://bit.ly/4eiaXYt
17 NSLHD 2025 Year in Review
Ryde Hospital staff celebrate end of early works
NSLHD Chief Executive Anthony Schembri and Ryde Hospital General Manager Jennifer McConnell joined by builders
To mark the end of early works for the Ryde Hospital redevelopment, staff came together for a well-earned BBQ celebration that was hosted by the project’s construction partner A W Edwards. The BBQ was a chance for staff to reflect on the progress so far, connect with colleagues, and look ahead to the next exciting chapter. NSLHD Chief Executive Anthony Schembri attended the celebration alongside Ryde Hospital General Manager Jennifer McConnell and Leisa Rathborne, Health Infrastructure’s Acting Executive Director (Northern).
Staff enjoying the BBQ
“Thank you to everyone who has played a part in getting us to this milestone in the redevelopment.”
“The redevelopment will deliver modern, purpose-built facilities to support high-quality care for the Ryde community,” Anthony said.
18 NSLHD 2025 Year in Review
NSLHD staff shine at inaugural 2025 SDPR Awards
NSLHD staff at the 2025 SDPR Awards, in front of the Aboriginal artwork unveiled at the ceremony by Wodi Wodi, Worimi and Yuin Nation artist Lee Anthony Hampton
NSLHD staff were among the standout finalists and winners at the inaugural 2025 Single Digital
NSLHD had a strong showing across several categories: Winner – SDPR Challenger Team Award: Greg Donald (RNSH Shared Services) with the SDPRIA Hosting and Technical Architecture Team. Winner – Putting Patients First (Team Award): Helen Goodwin, Tavia Bernsdorff, and Katherine Peverell for their work on the SDPR Paediatric Council. Winner – Configuration Champion (Team Award): AnneMarie Hall for her contribution to the Alcohol and Other Drugs Specialty Content Group. Finalist – Putting Patients First: Thelma De Lisser Howarth, Erin Hoyer, and Nicola Richards from the SDPR Consumer Experience Council. Finalist – Excellence in Leadership (Team Award): Bronwyn Nolan (NSLHD) and Kay Duckinson (ISLHD).
Patient Record (SDPR) Awards.
Single Digital Patient Record Authority Chief Executive Dr Teresa Anderson AM praised all 364 individual and team finalists for their outstanding work in delivering digital transformation across NSW Health.
For more information on SDPR, visit: https://bit.ly/4eiaXYt
19 NSLHD 2025 Year in Review
At just 18, Lukas McHugh never imagined he could have a stroke. But one morning, he woke up unable to move the left side of his body. “I thought I’d just slept on it Teen’s shock stroke experience brings a new outlook on life
funny—I felt pins and needles. I didn’t know that was a sign of a stroke,” Lukas said. Realising something was seriously wrong, he called an ambulance and was rushed to Royal North Shore Hospital (RNSH), where the stroke team acted immediately. “The patient had classic stroke symptoms—left-sided weakness, facial droop, and limb drift,” said Sheila Jala, stroke clinical nurse consultant. “Thanks to the team’s rapid response, we achieved a door-to-needle time of just 16 minutes and a door-to-groin time of 57 minutes.” Door-to-needle time refers to the crucial window from hospital arrival to receiving clot-busting treatment. Faster treatment leads to better recovery outcomes. Door-to-groin time is the time from a patient’s arrival at the hospital to the start of a procedure involving catheter insertion in the groin. This metric is important because the faster the treatment starts after arrival, the better the chances of a good outcome, especially in time- sensitive conditions like stroke. Now on the road to recovery, Lukas is grateful. “The nurses were lovely, the doctors were informative, and they were always open to speak and answer all my questions. The student nurses from NSLHD were also fantastic—so supportive and attentive,” he said. His experience has changed his perspective on life.
Lukas McHugh (left) with a friend
“You’re not invincible. You have to take care of yourself. I appreciate more now—study, work, everything I can do.”
20 NSLHD 2025 Year in Review
Large grant to reduce the devastating impact of septic shock
Executive Director of Research Associate Professor Naomi Hammond
NSLHD Executive Director of Research, Associate Professor Naomi Hammond, is leading a first-of-its-kind study, assessing if a combination steroid therapy can reduce deaths and improve recovery following septic shock.
of whether fludrocortisone and hydrocortisone are effective, we could make a huge impact globally on patient survival, recovery and the economic burden.”
Close to $5 million was awarded to the study through the Federal Government’s Clinical Trials Activity program. Dubbed FINESSE, the clinical trial will explore the impact of fludrocortisone on its own and combined with hydrocortisone on critically ill patients with septic shock. Naomi said sepsis was a global public health challenge which claimed 11 million lives a year, including around 9,000 people in Australia alone. “Sepsis research has been characterised by many failed trials, with over 30 per cent of people [with sepsis] losing their
lives to the condition over the last 10 years,” she said. “This mortality rate remains unacceptably high, demonstrating the need for further research.” Some studies suggest combining hydrocortisone with fludrocortisone can reduce the risk of death, however, without substantial evidence, many doctors are unsure about its use and proper dosage. “The use of steroids has been controversial for over 70 years,” she said. “Our study however, has the potential to reduce death and long-term disability. By answering the lingering question
These medications are both low-cost, widely available
medicines. Improving recovery time by just one day for 55,000 patients in Australia would save $122 million a year in healthcare costs. The trial is being supported by RNSH’s Intensive Care Unit clinicians Associate Professor Anthony Delaney, Dr Chris Anderson, Dr Lachlan Donaldson and Frances Bass. Key collaborators include The George Institute of Global Health and Sepsis Australia.
21 NSLHD 2025 Year in Review
Medical plastics recycled in new trial
Staff at RNSH with the new green bins
Royal North Shore Hospital has partnered with the manufacturer, Arjo, and joined its ReNu recycling program, in the first program of its kind in a NSW public hospital aimed at reducing waste from the use of compression sleeves.
It is estimated that 14,000 compression sleeves are used across the district in a 12-month period, as part of the standard deep vein thrombosis prevention strategy, resulting in nearly three tonnes of plastic waste. Under the new program, staff have been provided with biodegradable collection bags to place used sleeves during routine care in post-operative wards. The program presents a significant opportunity to reduce environmental impact and improves how clinical waste is managed at RNSH. The bags are picked up during regular waste rounds and
transferred to a central bin at the hospital’s loading dock, where Arjo collects the contents for recycling on a weekly basis. NSLHD Sustainable Procurement Implementation Manager David Russell said the program marked an important step in planetary health. “Our clinical products and plastic waste are a big part of our emissions, and we’re aiming to cut those emissions in half by 2035,” he said. “Implementing programs like Arjo’s ReNu program at RNSH can
demonstrate how working with suppliers helps to reduce waste, lower emissions and save money, as we strive to continue leading the way in planetary health as a district.” This initiative is one of many supplier-supported opportunities that NSLHD has evaluated and began implementing on its journey to being the leading district in planetary health in the state. The program also supports the goals of the NSLHD Planetary Health Framework 2024–2027, particularly around improving recycling and participating in supplier-led sustainability efforts.
22 NSLHD 2025 Year in Review
NSLHD finalists in Allied Health Awards
Two outstanding NSLHD allied health professionals were named finalists in the NSW Health 2025 Excellence in Allied Health Awards. Dr Sally Wootton, physiotherapist, was nominated as a finalist for Allied Health Professional of the Year, while Christy El-Khoury, pharmacist, was nominated as a finalist for Early Career Allied Health Professional of the Year. These prestigious awards celebrate the dedication and exceptional care provided by NSW allied health professionals. Sally, who is also a clinical senior lecturer at the University of Sydney, is a leading clinical researcher in pulmonary rehabilitation. With over 40 publications and contributions to international guidelines, her research has transformed respiratory care, including through Australia’s first mobile pulmonary rehabilitation platform. Christy El-Khoury joined Royal North Shore Hospital after completing her pharmacy internship in 2023. She has quickly distinguished herself through her leadership in a district-wide penicillin allergy de- labelling project, aiming to optimise patient outcomes and improve antimicrobial stewardship. As one of NSW’s Advanced Pharmacy Australia Foundation Pharmacy Residents, she is expanding her clinical expertise while driving hospital wide improvements. “Hearing that I was a finalist was an incredible surprise and an honour. It’s wonderful to see pharmacists recognised for their contributions,” Christy said. “Being a finalist is a great honour and a testament to my incredible team. Our focus is on ensuring all patients receive the best care through innovation and evidence-based practice.” Julia Capper, Executive Director, Allied Health, NSLHD, said it was a fantastic achievement to have finalists in these awards. “We are so fortunate to have such amazing allied health team members,” she said.
Dr Sally Wootton
Christy El-Khoury
23 NSLHD 2025 Year in Review
Pioneering MuscleMap project secures strong philanthropic support A project to develop an innovative tool which could revolutionise the detection and treatment of musculoskeletal and neurological conditions has received a $230,000 gift.
The anonymous donation was made following a campaign by the University of Sydney and the NORTH Foundation to support the world’s first, open- source dataset of whole-body muscle composition. The Kolling Institute’s Academic Director Professor James Elliott said there was a critical need for the diagnostic tool, with muscle and neurological conditions among the leading causes of illness and disability worldwide. “With these conditions affecting more than four billion people, they are expected to cost around $21 billion in healthcare expenditure by 2033 in Australia alone,” he said. “Early identification and intervention are crucial if we are to offer long-term health benefits and minimise the disease burden. “We know these conditions often lead to a steady decline in muscle health, and this decline is evident by an increase in fat deposits in the muscles and the loss of muscle fibres. “CT and MRI scans can be used to identify these changes, but the time it currently takes is prohibitive.” The MuscleMap approach however, will automatically identify any changes, potentially revolutionising the detection
of muscle health in any part of the body. It could inform
treatment for everyone from elite athletes to astronauts and older people with complex conditions. Astronauts for instance, experience significant muscle
loss due to the effects of exposure to zero gravity.
Using existing MRI and CT scans, the landmark global study has applied an artificial intelligence model to produce a dataset of muscle health of any part of the body. This will enable a patient’s muscle deterioration to be compared with a healthy person’s. James said it will mean a clinician will be able to upload a scan into the MuscleMap program, and within minutes, will have access to detailed information measuring muscle composition compared to a reference dataset. “For athletes and the general population, the tool will accurately inform the journey from injury
Professor James Elliott
to repair, recovery and return to physical activity,” he said. “We are very appreciative of this generous donation to the MuscleMap project. “It will be a pioneering resource, accessible to clinicians and researchers globally, and supporting the long-term health of communities.”
“For patients with osteoporosis, the program will provide a detailed analysis of overall health and muscle deterioration, which will then inform personalised strategies to develop healthier muscle mass and improve general health and wellbeing.”
24 NSLHD 2025 Year in Review
NSLHD and TAFE NSW become partners to strengthen First Nation’s workforce support
NSLHD graduates of the inaugural Aboriginal and Torres Strait Islander mentoring program
An inaugural mentoring program focused on supporting and strengthening cultural capability was held by the district in collaboration with TAFE NSW. The program is designed for non-Indigenous staff, to develop the knowledge and confidence to work respectfully with Aboriginal and Torres Strait Islander people, communities and colleagues.
“Increasing Aboriginal and Torres Strait Islander representation, particularly in leadership roles, enhances decision-making and ensures our services are more culturally responsive and aligned to the needs of First Nations communities.”
The pilot initiative was a first for the district which saw 13 participants complete a formal cultural mentoring program. It was established in response to feedback received through the NSLHD Muru Dali Gili Gili Employee Network, to better support workforce development. Kuibuz Adidi, Aboriginal and Torres Strait Islander workforce manager, said the program aimed to build mentoring capabilities across the organisation by
increasing the number of mentors with cross-cultural competence. “Thirteen participants — including four First Nations and nine Non-First Nations staff — have now graduated, each receiving a Statement of Attainment in Mentoring Aboriginal and/or Torres Strait Islander People,” she said. “We know that when our workforce reflects the communities we serve and truly values cultural difference, we create stronger, more inclusive health services.
25 NSLHD 2025 Year in Review
Hornsby Ku-ring-gai Hospital Connected to Country
Staff were all smiles at the opening of the new yarning circle
A yarning circle was opened to patients and staff at Hornsby Ku-ring-gai Hospital (HKH), recognising the Indigenous communities and connection to the area.
The long-awaited opening of the yarning circle was accompanied by a smoking ceremony as staff and guests came together to mark its significance. Designed with Aboriginal elders and the NSLHD Aboriginal and Torres Strait Islander Health Service, the yarning circle is a special feature on the campus,
HKH General Manager Simon Hill said he hoped many people would use the special space to come together and reflect, talk. “A yarning circle is one of those key elements of Indigenous culture, where decisions are made collaboratively and through inclusive dialogue,” he said. “The yarning circle complements the other
culturally significant places of recognition that are on campus: from the beautiful artwork in the stairwell in the main building, to the naming of the building, Muru Jannawi (which means ‘take this path with us’).” Hornsby Hospital also has artwork installations outside Bungee Bidgel, Sorry Business Area, and the Childhood Community Centre.
taking in the landscape and enjoys a view of the campus.
Smoking ceremony at the opening
26 NSLHD 2025 Year in Review
Celebrating the quiet achievers behind our clinical trial success
Associate Professor Mark Montebello, Professor Rory Clifton Bligh, Rebecca Stevenson, Dr Eveline Staub and Professor Jeremy Booth
International Clinical Trials Day provided the chance to recognise the many people contributing to our life-changing clinical trials.
More than 250 trials were underway across the district including innovative projects at Royal North Shore Hospital, Hornsby Ku-ring-gai,
“We are building our world-class expertise, while extending our activity and capabilities. “I would like to recognise the hundreds of staff behind the scenes whose expertise and commitment ensure our trials are run safely, ethically and with care. “And at the heart of every breakthrough are the patients who generously volunteer to take part in clinical trials. We are deeply grateful for their contributions and participation.” The district will establish a dedicated clinical trials centre to extend access to cutting-edge therapies. The NORTH STAR VNP will offer hope to millions of people with cancer and non- cancer related conditions. Head of the non-cancer stream Professor Rory Clifton-Bligh said
NORTH STAR VNP will bring together world-leading clinical triallists, delivering benefits for patients and the broader community. “These trials will continue to advance our understanding, develop new treatments, and improve how we prevent, diagnose and manage conditions,” he said. “NORTH STAR VNP will expand the quality and quantity of our trials, nurture our trials workforce and strengthen partnerships with industry at all stages of the therapy pipeline. “It will offer access to leading specialists, the latest breakthroughs and high standards of care.”
Ryde, Macquarie and Mona Vale hospitals.
These trials are the key to medical progress, from the medications we take to the procedures we undergo and the technologies that improve our lives. NSLHD Chief Executive Anthony Schembri thanked the large trials workforce for its commitment to exceptional research. “At Northern Sydney, the district is embedding trials as therapy, integrating them into standard care so that all patients have access to the very latest medical innovations,” he said.
27 NSLHD 2025 Year in Review
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Page 38 Page 39 Page 40 Page 41 Page 42 Page 43 Page 44 Page 45 Page 46 Page 47 Page 48 Page 49 Page 50 Page 51 Page 52Made with FlippingBook - professional solution for displaying marketing and sales documents online